BFI Co., LLC
SEC CIK 1601607 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PAHC | PHIBRO ANIMAL HEALTH CORP | 10% | 8,520 | — | $15.85M | 22 | 2025-09-30 | 2026-02-24 |
Most active insiders at PAHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BFI Co., LLC | 10% | — | $15.85M |
| 2 | BENDHEIM JACK | Pres, CEO, Dir, 10% | — | $15.01M |
| 3 | CORCORAN E THOMAS | Dir | $317.7K | — |
| 4 | Rodriguez Patrick | VP Fin, Treas | — | — |
| 5 | Weinstein Judith | See Remarks | — | — |
| 6 | BENDHEIM Jonathan | Dir | — | — |
| 7 | Escudero Lisa Ann | See Remarks | — | — |
| 8 | David Glenn | CFO | — | — |
| 9 | Miller Larry Lee | COO | — | — |
| 10 | Bendheim Daniel M | Pres, CEO, Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-02-26 | 2026-02-24+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $52.27 | -21.1K | 8,520 | -71% | -$1.10M |
| MI | 2026-02-23 | 2026-02-19+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $50.84 | -14.1K | 22.6K | -38% | -$715.8K |
| MI | 2026-02-18 | 2026-02-13+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $51.68 | -14.1K | 36.9K | -28% | -$727.6K |
| DMI | 2026-02-09 | 2026-02-05 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $48.38 | -110.8K | 226.6K | -33% | -$5.36M |
| DI | 2026-02-09 | 2026-02-05 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | C - Cnv Deriv | $0.00 | +185.0K | 233.8K | +379% | $0 |
| MI | 2026-02-02 | 2026-01-29+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.11 | -13.5K | 32.0K | -30% | -$540.0K |
| DMI | 2026-01-15 | 2026-01-13+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.31 | -14.1K | 44.5K | -24% | -$569.8K |
| DI | 2026-01-15 | 2026-01-14 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | C - Cnv Deriv | $0.00 | +20.0K | 51.1K | +64% | $0 |
| I | 2026-01-13 | 2026-01-09 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.16 | -213 | 38.7K | -0.5% | -$8,554 |
| MI | 2025-12-15 | 2025-12-11 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.93 | -5,752 | 39.2K | -13% | -$235.4K |
| DMI | 2025-12-04 | 2025-12-03+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $41.00 | -7,040 | 49.8K | -12% | -$288.6K |
| DI | 2025-12-04 | 2025-12-03 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | C - Cnv Deriv | $0.00 | +30.0K | 56.8K | +112% | $0 |
| MI | 2025-12-02 | 2025-11-28+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $42.10 | -7,040 | 26.8K | -21% | -$296.4K |
| MI | 2025-11-26 | 2025-11-25+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $43.97 | -12.3K | 39.1K | -24% | -$541.7K |
| MI | 2025-11-24 | 2025-11-20 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $41.76 | -3,520 | 46.2K | -7% | -$147.0K |
| DMI | 2025-11-18 | 2025-11-17+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $44.19 | -10.6K | 49.7K | -18% | -$466.7K |
| DI | 2025-11-18 | 2025-11-14 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | C - Cnv Deriv | $0.00 | +55.0K | 60.2K | +1,050% | $0 |
| DMI | 2025-11-13 | 2025-11-12+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $45.01 | -30.3K | 5,240 | -85% | -$1.37M |
| DI | 2025-11-13 | 2025-11-11 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | C - Cnv Deriv | $0.00 | +15.0K | 35.6K | +73% | $0 |
| MI | 2025-11-10 | 2025-11-07+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $45.08 | -41.8K | 40.7K | -51% | -$1.89M |
| MI | 2025-10-24 | 2025-10-22+ | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.53 | -18.9K | 58.5K | -24% | -$766.0K |
| I | 2025-10-01 | 2025-09-30 | PAHC | PHIBRO ANIMAL HEALTH CORP | BFI Co., LLC | 10% | S - Sale | $40.38 | -20.7K | 40.7K | -34% | -$834.4K |
Purchase Sale Sale after option exercise All abbreviations